3.1 Study characteristics
Two studies were randomised controlled trials with a total of 7,248
participants randomised, conducted in Canada, and across multiple
countries. (31, 32) The two observational studies were both conducted in
the United Kingdom. (27, 28) Three studies (27, 28, 31) were implemented
in a primary care setting, and one implemented in ‘centres’ across
multiple countries. (32) A total of 1,302 participants were prescribed a
gabapentinoid at baseline. One study had industry sponsorship for
editorial support for manuscript preparation. (32) A summary of the
study characteristics are reported in Table 1 and the interventions in
Table 2.